Praemium Ltd (PPS)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.570 |
|---|---|
| 52-week range | 0.528 – 0.911 |
| Return, 1 month / 3 months | −3.4% / −18.1% |
| Return, 1 year / 3 years | −33.9% / +13.0% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 45.2% |
| Worst drawdown (1 year) | -41.2% |
| Average daily value traded | 0.83M AUD |
| Dividend yield | 4.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Praemium is an Australian financial technology company based in Melbourne that provides portfolio administration and investment platform services. It serves financial advisers, wealth managers and their clients through platforms that handle separately managed accounts, investment reporting and administration of client portfolios. Its software and services help advisers manage and report on investments across different asset types, and the company also offers services for international clients through its platform operations.
Praemium Ltd trades under the code PPS on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Praemium Ltd (PPS) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.570 on 19 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 804 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 33.9% and over the last three months it fell 18.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -15.9% | ||
| From 52-week high | -36.8% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -18.1% | ||
| 6-month return | -19.8% | ||
| 12-month return, skipping the last month | -31.6% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.2% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 0.83M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.4% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −8.8% |
|---|---|
| 1 month | −3.4% |
| 3 months | −18.1% |
| 6 months | −19.8% |
| 1 year | −33.9% |
| 3 years | +13.0% |
| 5 years | −43.4% |
Signals
| 50-day / 200-day average | 0.627 / 0.678 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.026 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | AUD 0.0125 |
| 5 Mar 2026 | AUD 0.0125 |
| 3 Sep 2025 | AUD 0.0125 |
| 6 Mar 2025 | AUD 0.0100 |
| 4 Sep 2024 | AUD 0.0100 |
| 25 Jul 2022 | AUD 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.